Aztreonam Market Gains Momentum Driven by Increasing Demand for Advanced Antibiotic Therapies
Aztreonam — a monobactam antibiotic long prized for its activity against aerobic Gram-negative bacteria and its safety in patients with penicillin allergy — has evolved from a niche hospital product into a strategically important asset in the anti-infective portfolio. Its expanding clinical role, new combination therapies, and shifting commercial ownership have combined to reshape the market … Read more